Albert Bourla supports the idea of primary vaccination against coronavirus on a three-dose basis
Albert Bourla supports the i...
Subscribe to Newsletter

Albert Bourla supports the idea of primary vaccination against coronavirus on a three-dose basis

17 January 2022
2 min.
Albert Bourla supports the idea of primary vaccination against coronavirus on a three-dose basis

Vaccination against COVID

Albert Bourla, CEO of the US pharmaceutical company Pfizer, believes it is necessary to vaccinate people with three doses of the coronavirus vaccine to fight the pandemic more effectively and to revaccinate annually. He expressed this opinion on BFM television on Monday.

"We don't have any data yet on when the fourth dose of the vaccine will be needed. But I have said many times: in my view, three doses are needed to complete the vaccination cycle, then one dose per year, except for the most vulnerable citizens who could be vaccinated every quarter," he said.

Pfizer is studying the effectiveness of the fourth dose of vaccination and does not expect to have results until March. At the same time, data on a new coronavirus vaccine, which will be better adapted to the new strains, will be available, he added.

The CEO said the company had produced around 3 billion doses of the coronavirus vaccine by the end of 2021. 2.6 billion doses were destined for export, of which 40% were supplied to developing countries. For 2020, Pfizer earned about $36 billion from these vaccines.

Investment in France

Bourla spoke about plans to launch Paxlovid, a drug designed to treat COVID-19 and prevent severe disease.

"We have big plans to invest in France, we intend to invest €520m over five years. Most of this investment will go towards a partnership with Novacep in Murens in the south of France to produce the active pharmaceutical ingredient of this drug for the world," said the CEO of the US pharmaceutical giant.

Paxlovid comes in the form of two kinds of tablets, which must be taken together twice a day for five days.

Paxlovid reduces the risk of hospitalisation or death after being infected with the coronavirus by 89%, according to data from phase two trials. The US Department of Health and Human ServicesFood and Drug Administration approved the drug for emergency use on 22 December last year.

Persons1 and Companies3 in the news

Chairman and Chief Executive Officer of Pfizer
1 place
3 place
Source foto:
Rating companies
15 Mention
14 Mention
14 Mention
JP Morgan Chase
11 Mention
10 Mention
Ford Motor Company
10 Mention
8 Mention
White House
7 Mention


News from is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York. news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova

Development Director
Died this year
Born this year